University of North Carolina School of Law, NC, USA.
J Law Med Ethics. 2011 Fall;39(3):437-49. doi: 10.1111/j.1748-720X.2011.00613.x.
The Patient Protection and Affordable Care Act created the nation's first comprehensive comparative effectiveness research (CER) program. According to some optimistic accounts, CER will revolutionize clinical practice and transform the health care delivery system. But what about public health? There are reasons for concern that it could end up left behind in the new era of comparative effectiveness. This article analyzes the considerable promise and serious limitations of applying CER to public health. It also highlights important issues that will likely emerge for public health law and policy as the health care system transitions to greater reliance on CER.
《患者保护与平价医疗法案》创立了美国首个综合性的比较效果研究（CER）项目。根据一些乐观的说法，CER 将彻底改变临床实践并改变医疗服务提供系统。但是公共卫生呢？有人担心，在比较效果的新时代，公共卫生可能会落后。本文分析了将 CER 应用于公共卫生的巨大潜力和严重限制。它还强调了随着医疗保健系统越来越依赖 CER，公共卫生法和政策可能出现的重要问题。
